Assembly Biosciences, Inc. (ASMB) Shareholders’ equity 2016–2025
Assembly Biosciences, Inc. (ASMB) shareholders’ equity at each fiscal year-end, per SEC filings.
$206.8MFY2025 · since FY2016: $79.9M → $206.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $206.8M | +519.8% |
| FY2024 | $33.4M | -18.8% |
| FY2023 | $41.1M | -50.3% |
| FY2022 | $82.7M | -51.1% |
| FY2021 | $168.9M | -29.8% |
| FY2020 | $240.6M | -11.9% |
| FY2019 | $273.2M | +29.7% |
| FY2018 | $210.7M | +86.2% |
| FY2017 | $113.1M | +41.6% |
| FY2016 | $79.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice